Skip to main content

Vasculitis

  • Chapter
  • First Online:
  • 1440 Accesses

Abstract

Vasculitis is defined by the presence of inflammation within the blood vessel wall, which can result in vascular aneurysms or conversely vessel stenosis or occlusion. Vasculitis can occur secondary to a wide range of underlying causes or a primary vasculitic disease for which the underlying etiology has not yet been identified. Although immunosuppressive therapy represents the foundation of treatment for active vasculitis, vascular surgeons play an important role in the management of emergent or elective complications of vasculitis affecting the medium to large sized arteries. Polyarteritis nodosa, giant cell arteritis, and Takayasu arteritis are the primary vasculitic diseases that most prominently affect these vessels and represent the vasculitides most commonly encountered by vascular surgeons.

This is a preview of subscription content, log in via an institution.

Buying options

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   39.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD   54.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

References

  1. Jennette JC, Falk RJ, Bacon PA, et al. 2012 revised international Chapel Hill consensus conference nomenclature of vasculitides. Arthritis Rheum. 2013;65(1):1–11.

    Article  PubMed  CAS  Google Scholar 

  2. Pagnoux C, Seror R, Henegar C, et al. Clinical features and outcomes in 348 patients with polyarteritis nodosa: a systematic retrospective study of patients diagnosed between 1963 and 2005 and entered into the French Vasculitis Study Group Database. Arthritis Rheum. 2010;62(2):616–26.

    Article  PubMed  Google Scholar 

  3. Levine SM, Hellmann DB, Stone JH. Gastrointestinal involvement in polyarteritis nodosa (1986-2000): presentation and outcomes in 24 patients. Am J Med. 2002;112(5):386–91.

    Article  PubMed  Google Scholar 

  4. Pagnoux C, Mahr A, Cohen P, et al. Presentation and outcome of gastrointestinal involvement in systemic necrotizing vasculitides: analysis of 62 patients with polyarteritis nodosa, microscopic polyangiitis, Wegener granulomatosis, Churg-Strauss syndrome, or rheumatoid arthritis-associated vasculitis. Medicine (Baltimore). 2005;84(2):115–28.

    Article  Google Scholar 

  5. Gayraud M, Guillevin L, le Toumelin P, et al. Long-term followup of polyarteritis nodosa, microscopic polyangiitis, and Churg-Strauss syndrome: analysis of four prospective trials including 278 patients. Arthritis Rheum. 2001;44(3):666–75.

    Article  PubMed  CAS  Google Scholar 

  6. Ribi C, Cohen P, Pagnoux C, et al. Treatment of polyarteritis nodosa and microscopic polyangiitis without poor-prognosis factors: a prospective randomized study of one hundred twenty-four patients. Arthritis Rheum. 2010;62(4):1186–97.

    Article  PubMed  Google Scholar 

  7. Guillevin L, Mahr A, Callard P, et al. Hepatitis B virus-associated polyarteritis nodosa: clinical characteristics, outcome, and impact of treatment in 115 patients. Medicine (Baltimore). 2005;84(5):313–22.

    Article  Google Scholar 

  8. Hernández-Rodríguez J, Molloy ES, Hoffman GS. Single-organ vasculitis. Curr Opin Rheumatol. 2008;20(1):40–6.

    Article  PubMed  Google Scholar 

  9. Parent BA, Cho SW, Buck DG, et al. Spontaneous rupture of hepatic artery aneurysm associated with polyarteritis nodosa. Am Surg. 2010;76(12):1416–9.

    PubMed  Google Scholar 

  10. Stambo GW, Guiney MJ, Cannella XF, et al. Coil embolization of multiple hepatic artery aneurysms in a patient with undiagnosed polyarteritis nodosa. J Vasc Surg. 2004;39(5):1122–4.

    Article  PubMed  Google Scholar 

  11. Salvarani C, Pipitone N, Versari A. Clinical features of polymyalgia rheumatica and giant cell arteritis. Nat Rev Rheumatol. 2012;8(9):509–21.

    Article  PubMed  CAS  Google Scholar 

  12. Bongartz T, Matteson EL. Large-vessel involvement in giant cell arteritis. Curr Opin Rheumatol. 2006;18(1):10–7.

    Article  PubMed  Google Scholar 

  13. Kermani TA, Warrington KJ, Crowson CS, et al. Large-vessel involvement in giant cell arteritis: a population-based cohort study of the incidence-trends and prognosis. Ann Rheum Dis. 2013;72(12):1989–94.

    Article  PubMed  Google Scholar 

  14. García-Martínez A, Arguis P, Prieto-González S, et al. Prospective long term follow-up of a cohort of patients with giant cell arteritis screened for aortic structural damage (aneurysm or dilatation). Ann Rheum Dis. 2013 Jul 19.

    Google Scholar 

  15. Schmidt WA, Kraft HE, Vorpahl K, et al. Color duplex ultrasonography in the diagnosis of temporal arteritis. N Engl J Med. 1997;337(19):1336–42.

    Article  PubMed  CAS  Google Scholar 

  16. Salvarani C, Silingardi M, Ghirarduzzi A, et al. Is duplex ultrasonography useful for the diagnosis of giant-cell arteritis? Ann Intern Med. 2002;137(4):232–8.

    Article  PubMed  Google Scholar 

  17. Aiello PD, Trautmann JC, McPhee TJ, et al. Visual prognosis in giant cell arteritis. Ophthalmology. 1993;100(4):550–5.

    Article  PubMed  CAS  Google Scholar 

  18. Nesher G, Berkun Y, Mates M, et al. Low-dose aspirin and prevention of cranial ischemic complications in giant cell arteritis. Arthritis Rheum. 2004;50(4):1332–7.

    Article  PubMed  CAS  Google Scholar 

  19. Hoffman GS, Cid MC, Hellmann DB, Guillevin L, et al. A multicenter, randomized, double-blind, placebo-controlled trial of adjuvant methotrexate treatment for giant cell arteritis. Arthritis Rheum. 2002;46(5):1309–18.

    Article  PubMed  CAS  Google Scholar 

  20. Hoffman GS, Cid MC, Rendt-Zagar KE, et al. Infliximab for maintenance of glucocorticosteroid-induced remission of giant cell arteritis: a randomized trial. Ann Intern Med. 2007;146(9):621–30.

    Article  PubMed  Google Scholar 

  21. Rojo-Leyva F, Ratliff NB, Cosgrove 3rd DM, et al. Study of 52 patients with idiopathic aortitis from a cohort of 1,204 surgical cases. Arthritis Rheum. 2000;43(4):901–7.

    Article  PubMed  CAS  Google Scholar 

  22. Liang KP, Chowdhary VR, Michet CJ, et al. Noninfectious ascending aortitis: a case series of 64 patients. J Rheumatol. 2009;36(10):2290–7.

    Article  PubMed  Google Scholar 

  23. Albacker T, Svensson L. Cardiothoracic surgery for Takayasu’s arteritis and ginat cell arteritis. In: Hoffman GS, Weyand CM, Langford CA, Goronzy JJ, editors. Inflammatory diseases of blood vessels. 2nd ed. Oxford: Wiley-Blackwell; 2012.

    Google Scholar 

  24. Rajani RR, Kashyap VS. Peripheral vascular surgery for large vessel vasculitis. In: Hoffman GS, Weyand CM, Langford CA, Goronzy JJ, editors. Inflammatory diseases of blood vessels. 2nd ed. Oxford: Wiley-Blackwell; 2012.

    Google Scholar 

  25. Kerr GS, Hallahan CW, Giordano J, et al. Takayasu arteritis. Ann Intern Med. 1994;120:919–29.

    Article  PubMed  CAS  Google Scholar 

  26. Maksimowicz-McKinnon K, Clark TM, Hoffman GS. Limitations of therapy and a guarded prognosis in an American cohort of Takayasu arteritis patients. Arthritis Rheum. 2007;56:1000–9.

    Article  PubMed  Google Scholar 

  27. Tso E, Flamm SD, White RD, et al. Takayasu arteritis: utility and limitations of magnetic resonance imaging in diagnosis and treatment. Arthritis Rheum. 2002;46(6):1634–42.

    Article  PubMed  Google Scholar 

  28. de Souza AW, Machado NP, Pereira VM, et al. Antiplatelet therapy for the prevention of arterial ischemic events in Takayasu arteritis. Circ J. 2010;74:1236–41.

    Article  PubMed  Google Scholar 

  29. Hoffman GS, Leavitt RY, Kerr GS, et al. Treatment of glucocorticoid-resistant or relapsing Takayasu arteritis with methotrexate. Arthritis Rheum. 1994;37:578–82.

    Article  PubMed  CAS  Google Scholar 

  30. Molloy ES, Langford CA, Clark TM, et al. Anti-tumour necrosis factor therapy in patients with refractory Takayasu arteritis: long-term follow-up. Ann Rheum Dis. 2008;67:1567–9.

    Article  PubMed  CAS  Google Scholar 

  31. Liang P, Tan-Ong M, Hoffman GS. Takayasu’s arteritis: vascular interventions and outcomes. J Rheumatol. 2004;31:102–6.

    PubMed  Google Scholar 

  32. Giordano JM, Leavitt RY, Hoffman GS, et al. Experience with surgical treatment for Takayasu’s disease. Surgery. 1991;109:252–8.

    PubMed  CAS  Google Scholar 

  33. Kim YW, Kim DI, Park YJ, et al. Surgical bypass vs endovascular treatment for patients with supra-aortic arterial occlusive disease due to Takayasu arteritis. J Vasc Surg. 2012;55:693–700.

    Article  PubMed  Google Scholar 

  34. Saadoun D, Lambert M, Mirault T, et al. Retrospective analysis of surgery versus endovascular intervention in Takayasu arteritis: a multicenter experience. Circulation. 2012;125:813–9.

    Article  PubMed  CAS  Google Scholar 

  35. Qureshi MA, Martin Z, Greenberg RK. Endovascular management of patients with Takayasu arteritis: stents versus stent grafts. Semin Vasc Surg. 2011;24:44–52.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Carol A. Langford M.D., M.H.S. .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2014 Springer Science+Business Media New York

About this chapter

Cite this chapter

Langford, C.A. (2014). Vasculitis. In: Shah, S., Clair, D. (eds) Cleveland Clinic Manual of Vascular Surgery. Springer, New York, NY. https://doi.org/10.1007/978-1-4939-1631-3_10

Download citation

  • DOI: https://doi.org/10.1007/978-1-4939-1631-3_10

  • Published:

  • Publisher Name: Springer, New York, NY

  • Print ISBN: 978-1-4939-1630-6

  • Online ISBN: 978-1-4939-1631-3

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics